GlassScriptPhysician profile
Timothy Kinsey
NPI 1669476586
$360.97
in general payments reported to CMS, 2019-2025
13 companies · $89.57 in 2025
The $89.57 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.65 · 2021: $33.37 · 2022: $62.08 · 2023: $41.77 · 2024: $117 · 2025: $89.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $76.35 | 2022-2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $73.38 | 2024-2025 | Caplyta |
| Sanofi Pasteur INC. | $31.88 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $25.03 | 2024 | |
| Boston Scientific Corporation | $23.01 | 2022 | |
| Supernus Pharmaceuticals, INC. | $21.11 | 2021 | |
| Daiichi Sankyo INC. | $21.00 | 2022 | |
| Genentech USA, INC. | $17.65 | 2020 | |
| Pfizer INC. | $17.53 | 2024 | |
| Dexcom, INC. | $14.59 | 2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2023 | Xifaxan, Trulance |
| Idorsia Pharmaceuticals US INC | $12.74 | 2023 | Quviviq |
| Novo Nordisk INC | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kinsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.